FELE vs SCWO: stock comparison and AI forecast
Franklin Electric Co Inc (FELE) and 374water Inc. (SCWO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
FELE Franklin Electric Co Inc
- Price
- $94.17 -5.8% · 6M
- Market Cap
- $4.16B
- P/E Ratio
- 21.7x
- Size
- mid-cap
- AI Forecast
SCWO 374water Inc.
- Price
- $2.43 +9.5% · 6M
- Market Cap
- $43M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- FELE is 96.6 times larger than SCWO by market capitalization ($4.16B against $43M).
- Over the last six months SCWO returned +9.5% and FELE -5.8%.
- FELE turns 8.8% of its revenue into net income, against -1056.2% for SCWO.
- SCWO carries 3.35 times debt per unit of equity, against 0.82 times for FELE.
- FELE yields 1.20% in dividends; SCWO pays none.
- Both companies share the SEC industry classification Motors & Generators.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | FELE | SCWO |
|---|---|---|
| Market Cap | $4.16B | $43M |
| P/E Ratio | 21.65x | – |
| P/B Ratio | 2.88x | 14.42x |
| Dividend Yield | 1.20% | – |
| EPS | $4.35 | $-0.93 |
| Book Value/Share | $32.74 | $0.17 |
| Revenue/Share | $51.25 | $0.11 |
| FCF/Share | $4.38 | $-0.67 |
Profitability & Margins
| Metric | FELE | SCWO |
|---|---|---|
| ROE | 13.8% | -668.5% |
| ROA | 7.6% | -153.6% |
| ROIC | 13.2% | – |
| Gross Margin | 35.4% | 6.2% |
| Operating Margin | 12.4% | -1002.2% |
| Net Margin | 8.8% | -1056.2% |
| EBT Margin | 11.7% | -1056.2% |
| Tax Rate | 23.8% | 0.0% |
Financial Health
| Metric | FELE | SCWO |
|---|---|---|
| Current Ratio | 2.33x | 1.67x |
| Quick Ratio | 1.12x | 1.22x |
| D/E Ratio | 0.82x | 3.35x |
| Financial Leverage | 1.82x | 4.35x |
| Interest Coverage | 18.5x | 1559.7x |
| Working Capital | $690M | $2M |
Cash Flow
| Metric | FELE | SCWO |
|---|---|---|
| Operating Cash Flow | $243M | -$9M |
| Free Cash Flow | $193M | -$12M |
| Capital Spending | -$50M | -$3M |
| OCF Growth YoY | -0.6% | – |
| FCF Growth YoY | -4.4% | – |
| FCF/Sales | 8.6% | -626.5% |
| CapEx/Sales | 2.2% | 150.2% |
Operational Efficiency
| Metric | FELE | SCWO |
|---|---|---|
| Asset Turnover | 0.86x | 0.15x |
| Receivables Turnover | 6.4x | 3.0x |
| Inventory Turnover | 2.3x | 1.1x |
| Fixed Assets Turnover | 8.1x | 0.4x |
| Days Sales Outstanding | 57 days | 120 days |
| Days Inventory | 156 days | 337 days |
| Payables Period | 54 days | 326 days |
| Cash Conversion Cycle | 160 days | 132 days |
Income Statement
| Metric | FELE | SCWO |
|---|---|---|
| Total Revenue | $2.26B | $2M |
| Operating Income | $280M | -$19M |
| Net Income | $200M | -$20M |
| R&D Expense | – | $2M |
| SG&A Expense | $512M | – |
| Cost of Goods Sold | $1.46B | $2M |
Dividend & Shareholder Information
| Metric | FELE | SCWO |
|---|---|---|
| Dividends Per Share | $1.13 | – |
| Payout Ratio | 26.0% | – |
| Shares Outstanding | 44M | 18M |
| Net Income Growth | 41.3% | – |
| EPS Growth | 39.9% | – |
FELE vs SCWO: stock comparison and AI forecast
Which is bigger, FELE or SCWO?
FELE is 96.6 times larger than SCWO by market capitalization ($4.16B against $43M).
Which stock performed better over the last six months, FELE or SCWO?
Over the last six months SCWO returned +9.5% and FELE -5.8%.
Which one does Intratio's AI model rank higher, FELE or SCWO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.